Dr. Harvey Pass
Dr. Harvey Pass is an accomplished, well-credentialed, and highly respected thoracic surgeon specializing in detecting, diagnosing, and treating pleural mesothelioma and lung cancer. He is also a renowned cancer researcher who pioneered groundbreaking studies in New York City and Michigan. Presently, Pass is a professor and the chief of Thoracic Oncology at the New York University Cancer Center, where he specializes in heart and chest, cancers affecting the chest, mesothelioma, and video-assisted thoracic surgeries. During his career as a thoracic surgeon and cancer researcher, Pass has helped develop blood tests to help detect mesothelioma. He was also one of the first thoracic surgeons to use intraoperative photodynamic therapy (PDT) and laser-activated injections.
Pass graduated from Johns Hopkins University as a member of the prestigious Phi Beta Kappa academic honor society. Pass completed his medical education, internship, and residency at Duke University between 1970 and 1980. He completed additional surgical training at the University of Mississippi, followed by training in specialized cardiothoracic surgery at the Medical University of South Carolina. Pass also completed a clinical fellowship in cardiothoracic surgery at the National Institute of Health between 1983 and 1986.
Professional Accomplishments
As an esteemed cancer researcher, Pass oversees laboratories at New York's Bellevue Hospital, which are responsible for conducting research on mesothelioma cancer markers, early detection methods, and efforts included in the Mesothelioma Pathogenesis Program Project. Pass also established a three-year Thoracic Fellowship Training Program at NYU. Between 1996 and 2005, Pass was responsible for much of the groundbreaking mesothelioma research and techniques pioneered by the acclaimed Karmanos Cancer Institute at Wayne State University in Michigan. Today, Pass is a member of the Lung Cancer Alliance Board and also serves as the chairman for the Scientific Advisory Board of the Mesothelioma Applied Research Foundation, an organization that he helped establish in 1998.
Pass' innovative research and groundbreaking treatment methods have earned him numerous awards, too. Pass was named one of Detroit's top doctors in 2004 and 2005 and has been included in Castle Connolly's prestigious list of America's top doctors for five years. His relentless research even led to the discovery of certain proteins, biomarkers, and innovative adjuvant therapies. As a result, Pass has had an enormous affect on mesothelioma diagnostic techniques and treatment methods. Although he currently sees patients in New York City, his work in Michigan has helped Wayne State's Karmanos Cancer Institute become one of the top mesothelioma treatment centers in the nation.
